Cencora (COR)
Largest Insider Buys in Sector
COR Stock Price History Chart
COR Stock Performance
About Cencora
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Insider Activity of Cencora
Over the last 12 months, insiders at Cencora have bought $109,290 and sold $2.53B worth of Cencora stock.
On average, over the past 5 years, insiders at Cencora have bought $109,290 and sold $1.55B worth of stock each year.
Highest buying activity among insiders over the last 12 months: DURCAN DERMOT MARK (director) — $218,580.
The last purchase of 500 shares for transaction amount of $109,290 was made by DURCAN DERMOT MARK (director) on 2024‑05‑24.
List of Insider Buy and Sell Transactions, Cencora
| 2024-12-20 | Sale | Executive Vice President | 1,678 0.0009% | $228.72 | $383,792 | +0.25% | ||
| 2024-12-03 | Sale | SVP & Chief Accounting Officer | 1,816 0.0009% | $250.41 | $454,754 | -7.26% | ||
| 2024-11-25 | Sale | Executive Chairman | 50,000 0.0251% | $243.97 | $12.2M | -4.50% | ||
| 2024-11-19 | Sale | Executive Chairman | 21,509 0.0107% | $242.16 | $5.21M | -1.84% | ||
| 2024-10-22 | Sale | Executive Chairman | 21,509 0.0104% | $235.80 | $5.07M | +1.25% | ||
| 2024-09-17 | Sale | Chairman, President & CEO | 21,509 0.0107% | $241.01 | $5.18M | -0.27% | ||
| 2024-08-20 | Sale | Chairman, President & CEO | 10,754 0.0053% | $239.13 | $2.57M | -1.48% | ||
| 2024-08-06 | Sale | Executive Vice President | 1,473 0.0007% | $242.69 | $357,482 | -1.26% | ||
| 2024-08-01 | Sale | 10 percent owner | 4.44M 2.1959% | $240.56 | $1.07B | -3.07% | ||
| 2024-07-16 | Sale | Chairman, President & CEO | 10,755 0.0049% | $222.12 | $2.39M | +4.78% | ||
| 2024-06-18 | Sale | Chairman, President & CEO | 10,754 0.0052% | $235.76 | $2.54M | -0.91% | ||
| 2024-05-31 | Sale | Executive Vice President | 1,874 0.0009% | $223.86 | $419,506 | +3.70% | ||
| 2024-05-29 | Sale | Executive Vice President | 27,093 0.012% | $216.07 | $5.85M | +7.18% | ||
| 2024-05-24 | director | 500 0.0002% | $218.58 | $109,290 | +7.22% | |||
| 2024-05-22 | Sale | 10 percent owner | 1.86M 0.8227% | $215.12 | $400M | +8.27% | ||
| 2024-05-21 | Sale | Chairman, President & CEO | 10,755 0.0049% | $221.30 | $2.38M | +8.08% | ||
| 2024-04-16 | Sale | Chairman, President & CEO | 10,754 0.0053% | $237.48 | $2.55M | -1.40% | ||
| 2024-04-15 | Sale | Executive Vice President & COO | 57,564 0.0278% | $235.09 | $13.53M | +0.33% | ||
| 2024-03-19 | Sale | Chairman, President & CEO | 10,755 0.0053% | $240.21 | $2.58M | -2.81% | ||
| 2024-03-18 | Sale | Executive Vice President | 9,644 0.0047% | $238.12 | $2.3M | -1.56% |
Insider Historical Profitability
| Walgreens Boots Alliance, Inc. | 10 percent owner | 19980000 10.3373% | $240.49 | 0 | 3 | |
| COLLIS STEVEN H | Executive Chairman | 326557 0.169% | $240.49 | 0 | 10 | |
| Mauch Robert P. | Executive Vice President & COO | 24412 0.0126% | $240.49 | 0 | 1 | |
| Krikorian Lazarus | SVP & Chief Accounting Officer | 21988 0.0114% | $240.49 | 0 | 1 | |
| DURCAN DERMOT MARK | director | 21876 0.0113% | $240.49 | 1 | 0 | |
| Battaglia Silvana | Executive Vice President | 20329 0.0105% | $240.49 | 0 | 2 | |
| Clark Gina | Executive Vice President | 13284 0.0069% | $240.49 | 0 | 4 | |
| Campbell Elizabeth S | Executive Vice President | 8246 0.0043% | $240.49 | 0 | 1 | |
| Szurek Paul E. | President & CEO | 242347 0.1254% | $240.49 | 3 | 13 | +8.95% |
| COLEMAN JAMES H | Sr. VP, Business Development | 200397 0.1037% | $240.49 | 1 | 0 | <0.0001% |
| STOLL ROGER G PHD | Chief Executive Officer | 100000 0.0517% | $240.49 | 7 | 0 | <0.0001% |
| DRAKE PETER F | director | 50000 0.0259% | $240.49 | 1 | 0 | <0.0001% |
| Rockwood Robert K. | SVP, General Management | 39868 0.0206% | $240.49 | 0 | 7 | |
| STAPLE PETER D | President & CEO | 34878 0.018% | $240.49 | 2 | 0 | +13.64% |
| ALLNUTT ROBERT | director | 30000 0.0155% | $240.49 | 1 | 0 | +9.77% |
| Tran Pierre V | Chief Medical Officer | 30000 0.0155% | $240.49 | 1 | 0 | <0.0001% |
| TOLLEFSON GARY D | director | 28000 0.0145% | $240.49 | 1 | 0 | <0.0001% |
| Warren Brian | SVP, Engineering & Product | 25121 0.013% | $240.49 | 0 | 36 | |
| Tobin Dominic M. | SVP, Operations | 23892 0.0124% | $240.49 | 2 | 28 | +21.23% |
| Dunn David W. | SVP, Mergers and Acquisitions | 19171 0.0099% | $240.49 | 1 | 1 | +19.98% |
| MESSINGER MARIA S | Chief Financial Officer | 15000 0.0078% | $240.49 | 1 | 0 | <0.0001% |
| Hatzenbuehler Anthony | SVP, Field Operations | 13639 0.0071% | $240.49 | 0 | 5 | |
| Bair Christopher M. | SVP, Sales and Leasing | 11525 0.006% | $240.49 | 1 | 1 | +4.63% |
| Price Chuck D. | SVP, Information Technology | 9556 0.0049% | $240.49 | 1 | 0 | +20.35% |
| Thompson John David | director | 8629 0.0045% | $240.49 | 1 | 1 | +22.11% |
| Carlyle Realty III, GP, L.L.C. | 10 percent owner | 0 0% | $240.49 | 0 | 8 | |
| Carlyle Realty V GP, L.L.C. | 10 percent owner | 0 0% | $240.49 | 0 | 2 | |
| CRP IV AIV GP, L.L.C. | 10 percent owner | 0 0% | $240.49 | 0 | 8 | |
| Carlyle Group Management L.L.C. | 10 percent owner | 0 0% | $240.49 | 0 | 9 |